HomeMIRA • NASDAQ
add
Mira Pharmaceuticals Inc
Previous close
$0.99
Day range
$0.98 - $1.08
Year range
$0.51 - $5.01
Market cap
17.56M USD
Avg Volume
2.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.44M | -20.24% |
Net income | -2.40M | 58.54% |
Net profit margin | — | — |
Earnings per share | -0.14 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.83M | -38.45% |
Total assets | 2.92M | -40.74% |
Total liabilities | 723.35K | 29.61% |
Total equity | 2.20M | — |
Shares outstanding | 16.81M | — |
Price to book | 7.65 | — |
Return on assets | -169.53% | — |
Return on capital | -211.12% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -2.40M | 58.54% |
Cash from operations | -1.81M | -74.40% |
Cash from investing | — | — |
Cash from financing | 493.40K | 313.83% |
Net change in cash | -1.31M | -3.62% |
Free cash flow | -914.49K | 79.35% |
About
Founded
2020
Headquarters
Website
Employees
3